Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 September 2006:
Vol. 313. no. 5792, pp. 1441 - 1443
DOI: 10.1126/science.1130256
Prev | Table of Contents | Next

Reports

Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins

Stephen R. Hamilton,1 Robert C. Davidson,1 Natarajan Sethuraman,1 Juergen H. Nett,1 Youwei Jiang,1 Sandra Rios,1 Piotr Bobrowicz,1 Terrance A. Stadheim,1 Huijuan Li,1 Byung-Kwon Choi,1 Daniel Hopkins,1 Harry Wischnewski,1 Jessica Roser,1 Teresa Mitchell,1 Rendall R. Strawbridge,2 Jack Hoopes,2 Stefan Wildt,1 Tillman U. Gerngross1,3*

Yeast is a widely used recombinant protein expression system. We expanded its utility by engineering the yeast Pichia pastoris to secrete human glycoproteins with fully complex terminally sialylated N-glycans. After the knockout of four genes to eliminate yeast-specific glycosylation, we introduced 14 heterologous genes, allowing us to replicate the sequential steps of human glycosylation. The reported cell lines produce complex glycoproteins with greater than 90% terminal sialylation. Finally, to demonstrate the utility of these yeast strains, functional recombinant erythropoietin was produced.

1 GlycoFi Inc., 21 Lafayette Street, Suite 200, Lebanon, NH 03766, USA.
2 Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766, USA.
3 Thayer School of Engineering, Department of Biological Sciences and Department of Chemistry, Dartmouth College, 8000 Cummings Hall, Hanover, NH 03755, USA.

* To whom correspondence should be addressed. E-mail: tillman.gerngross{at}dartmouth.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi {alpha}-Mannosidase II Locus.
M. Crispin, V. T. Chang, D. J. Harvey, R. A. Dwek, E. J. Evans, D. I. Stuart, E. Y. Jones, J. M. Lord, R. A. Spooner, and S. J. Davis (2009)
J. Biol. Chem. 284, 21684-21695
   Abstract »    Full Text »    PDF »
Streptococcus pneumoniae Endohexosaminidase D, Structural and Mechanistic Insight into Substrate-assisted Catalysis in Family 85 Glycoside Hydrolases.
D. W. Abbott, M. S. Macauley, D. J. Vocadlo, and A. B. Boraston (2009)
J. Biol. Chem. 284, 11676-11689
   Abstract »    Full Text »    PDF »
Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins.
H. Abe, Y. Takaoka, Y. Chiba, N. Sato, S. Ohgiya, A. Itadani, M. Hirashima, C. Shimoda, Y. Jigami, and K.-i. Nakayama (2009)
Glycobiology 19, 428-436
   Abstract »    Full Text »    PDF »
Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design.
T. A. Bowden, M. Crispin, D. J. Harvey, A. R. Aricescu, J. M. Grimes, E. Y. Jones, and D. I. Stuart (2008)
J. Virol. 82, 11628-11636
   Abstract »    Full Text »    PDF »
Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.
G.-C. Gil, W. H Velander, and K. E Van Cott (2008)
Glycobiology 18, 526-539
   Abstract »    Full Text »    PDF »
Engineering of mucin-type human glycoproteins in yeast cells.
K. Amano, Y. Chiba, Y. Kasahara, Y. Kato, M. K. Kaneko, A. Kuno, H. Ito, K. Kobayashi, J. Hirabayashi, Y. Jigami, et al. (2008)
PNAS 105, 3232-3237
   Abstract »    Full Text »    PDF »
N-Glycan Modification in Aspergillus Species.
E. Kainz, A. Gallmetzer, C. Hatzl, J. H. Nett, H. Li, T. Schinko, R. Pachlinger, H. Berger, Y. Reyes-Dominguez, A. Bernreiter, et al. (2008)
Appl. Envir. Microbiol. 74, 1076-1086
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)